Zynex, Inc. (ZYXI)
NASDAQ: ZYXI · Real-Time Price · USD
8.25
-0.15 (-1.79%)
Dec 20, 2024, 4:00 PM EST - Market closed
Zynex Employees
Zynex had 1,100 employees as of December 31, 2023. The number of employees increased by 200 or 22.22% compared to the previous year.
Employees
1,100
Change (1Y)
200
Growth (1Y)
22.22%
Revenue / Employee
$176,059
Profits / Employee
$4,385
Market Cap
262.73M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
Accolade | 2,400 |
Amylyx Pharmaceuticals | 384 |
Vanda Pharmaceuticals | 203 |
COMPASS Pathways | 186 |
AC Immune | 161 |
ProQR Therapeutics | 157 |
4D Molecular Therapeutics | 147 |
C4 Therapeutics | 145 |
ZYXI News
- 4 days ago - Zynex Announces Partnership To Conduct Business with Veterans Affairs (VA) Medical Centers, the Largest Healthcare Network in the United States - PRNewsWire
- 9 days ago - Zynex UCSF Study Results Demonstrate Laser Technology Benefits in Resolving Racial Bias of Current LED Pulse Oximeters - PRNewsWire
- 16 days ago - Zynex Announces Completion of Its Laser Pulse Oximetry Trial - PRNewsWire
- 18 days ago - Zynex Announces Open Oximetry Project Membership - PRNewsWire
- 2 months ago - Zynex, Inc. (ZYXI) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 2 months ago - Zynex Reports Third Quarter 2024 Financial Results - PRNewsWire
- 2 months ago - Zynex Sets Third Quarter 2024 Earnings Call - PRNewsWire
- 3 months ago - Zynex to Present at the HC Wainwright Global Investment Conference - PRNewsWire